These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 25744007)
1. Amyloid-beta (1-40) and the risk of death from cardiovascular causes in patients with coronary heart disease. Stamatelopoulos K; Sibbing D; Rallidis LS; Georgiopoulos G; Stakos D; Braun S; Gatsiou A; Sopova K; Kotakos C; Varounis C; Tellis CC; Kastritis E; Alevizaki M; Tselepis AD; Alexopoulos P; Laske C; Keller T; Kastrati A; Dimmeler S; Zeiher AM; Stellos K J Am Coll Cardiol; 2015 Mar; 65(9):904-16. PubMed ID: 25744007 [TBL] [Abstract][Full Text] [Related]
2. Association of contemporary sensitive troponin I levels at baseline and change at 1 year with long-term coronary events following myocardial infarction or unstable angina: results from the LIPID Study (Long-Term Intervention With Pravastatin in Ischaemic Disease). White HD; Tonkin A; Simes J; Stewart R; Mann K; Thompson P; Colquhoun D; West M; Nestel P; Sullivan D; Keech AC; Hunt D; Blankenberg S; J Am Coll Cardiol; 2014 Feb; 63(4):345-54. PubMed ID: 24140630 [TBL] [Abstract][Full Text] [Related]
3. Combined use of high-sensitivity cardiac troponin T and N-terminal pro-B type natriuretic peptide improves measurements of performance over established mortality risk factors in chronic heart failure. de Antonio M; Lupon J; Galan A; Vila J; Urrutia A; Bayes-Genis A Am Heart J; 2012 May; 163(5):821-8. PubMed ID: 22607860 [TBL] [Abstract][Full Text] [Related]
4. Amino-terminal pro-B-type natriuretic peptide and high-sensitivity C-reactive protein but not cystatin C predict cardiovascular events in male patients with peripheral artery disease independently of ambulatory pulse pressure. Skoglund PH; Arpegård J; Ostergren J; Svensson P Am J Hypertens; 2014 Mar; 27(3):363-71. PubMed ID: 24470529 [TBL] [Abstract][Full Text] [Related]
5. N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease. Kragelund C; Grønning B; Køber L; Hildebrandt P; Steffensen R N Engl J Med; 2005 Feb; 352(7):666-75. PubMed ID: 15716560 [TBL] [Abstract][Full Text] [Related]
6. Sex-Specific Association of Sleep Apnea Severity With Subclinical Myocardial Injury, Ventricular Hypertrophy, and Heart Failure Risk in a Community-Dwelling Cohort: The Atherosclerosis Risk in Communities-Sleep Heart Health Study. Roca GQ; Redline S; Claggett B; Bello N; Ballantyne CM; Solomon SD; Shah AM Circulation; 2015 Oct; 132(14):1329-37. PubMed ID: 26316620 [TBL] [Abstract][Full Text] [Related]
7. Amyloid-β (1-40) and Mortality in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome: A Cohort Study. Stamatelopoulos K; Mueller-Hennessen M; Georgiopoulos G; Sachse M; Boeddinghaus J; Sopova K; Gatsiou A; Amrhein C; Biener M; Vafaie M; Athanasouli F; Stakos D; Pateras K; Twerenbold R; Badertscher P; Nestelberger T; Dimmeler S; Katus HA; Zeiher AM; Mueller C; Giannitsis E; Stellos K Ann Intern Med; 2018 Jun; 168(12):855-865. PubMed ID: 29799975 [TBL] [Abstract][Full Text] [Related]
8. Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease. Lindahl B; Toss H; Siegbahn A; Venge P; Wallentin L N Engl J Med; 2000 Oct; 343(16):1139-47. PubMed ID: 11036119 [TBL] [Abstract][Full Text] [Related]
9. High-sensitivity cardiac troponin for risk prediction in patients with and without coronary heart disease. Hochholzer W; Valina CM; Stratz C; Amann M; Schlittenhardt D; Büttner HJ; Trenk D; Neumann FJ Int J Cardiol; 2014 Sep; 176(2):444-9. PubMed ID: 25127973 [TBL] [Abstract][Full Text] [Related]
10. Prognostic effect of high-sensitive troponin T assessment in elderly patients with chronic heart failure: results from the CORONA trial. Gravning J; Askevold ET; Nymo SH; Ueland T; Wikstrand J; McMurray JJ; Aukrust P; Gullestad L; Kjekshus J; Circ Heart Fail; 2014 Jan; 7(1):96-103. PubMed ID: 24284025 [TBL] [Abstract][Full Text] [Related]
11. Characteristics and baseline clinical predictors of future fatal versus nonfatal coronary heart disease events in older adults: the Cardiovascular Health Study. Pearte CA; Furberg CD; O'Meara ES; Psaty BM; Kuller L; Powe NR; Manolio T Circulation; 2006 May; 113(18):2177-85. PubMed ID: 16651468 [TBL] [Abstract][Full Text] [Related]
12. Traditional Risk Factors Versus Biomarkers for Prediction of Secondary Events in Patients With Stable Coronary Heart Disease: From the Heart and Soul Study. Beatty AL; Ku IA; Bibbins-Domingo K; Christenson RH; DeFilippi CR; Ganz P; Ix JH; Lloyd-Jones D; Omland T; Sabatine MS; Schiller NB; Shlipak MG; Skali H; Takeuchi M; Vittinghoff E; Whooley MA J Am Heart Assoc; 2015 Jul; 4(7):. PubMed ID: 26150476 [TBL] [Abstract][Full Text] [Related]
13. Prospective evaluation of the relationship between C-reactive protein, D-dimer and progression of peripheral arterial disease. Musicant SE; Taylor LM; Peters D; Schuff RA; Urankar R; Landry GJ; Moneta GL J Vasc Surg; 2006 Apr; 43(4):772-80; discussion 780. PubMed ID: 16616235 [TBL] [Abstract][Full Text] [Related]
14. Prognosis by C-reactive protein and matrix metalloproteinase-9 levels in stable coronary heart disease during 15 years of follow-up. Eldrup N; Kragelund C; Steffensen R; Nordestgaard BG Nutr Metab Cardiovasc Dis; 2012 Aug; 22(8):677-83. PubMed ID: 21194909 [TBL] [Abstract][Full Text] [Related]
15. Plasma lipoprotein(a) concentration predicts future coronary and cardiovascular events in patients with stable coronary heart disease. Nestel PJ; Barnes EH; Tonkin AM; Simes J; Fournier M; White HD; Colquhoun DM; Blankenberg S; Sullivan DR Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2902-8. PubMed ID: 24092750 [TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease. Sabatine MS; Morrow DA; Jablonski KA; Rice MM; Warnica JW; Domanski MJ; Hsia J; Gersh BJ; Rifai N; Ridker PM; Pfeffer MA; Braunwald E; Circulation; 2007 Mar; 115(12):1528-36. PubMed ID: 17372173 [TBL] [Abstract][Full Text] [Related]
17. Aldosterone, mortality, and acute ischaemic events in coronary artery disease patients outside the setting of acute myocardial infarction or heart failure. Ivanes F; Susen S; Mouquet F; Pigny P; Cuilleret F; Sautière K; Collet JP; Beygui F; Hennache B; Ennezat PV; Juthier F; Richard F; Dallongeville J; Hillaert MA; Doevendans PA; Jude B; Bertrand M; Montalescot G; Van Belle E Eur Heart J; 2012 Jan; 33(2):191-202. PubMed ID: 21719456 [TBL] [Abstract][Full Text] [Related]
18. High-sensitivity C-reactive protein is only weakly related to cardiovascular damage after adjustment for traditional cardiovascular risk factors. Olsen MH; Christensen MK; Hansen TW; Gustafsson F; Rasmussen S; Wachtell K; Borch-Johnsen K; Ibsen H; Jørgensen T; Hildebrandt P J Hypertens; 2006 Apr; 24(4):655-61. PubMed ID: 16531793 [TBL] [Abstract][Full Text] [Related]